{"id":2655,"date":"2019-11-07T20:57:45","date_gmt":"2019-11-08T01:57:45","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/hunter-shkolnik-discusses-tevas-23-billion-offer\/"},"modified":"2022-06-27T02:34:43","modified_gmt":"2022-06-27T06:34:43","slug":"hunter-shkolnik-discusses-tevas-23-billion-offer","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/en\/whitepapers\/hunter-shkolnik-discusses-tevas-23-billion-offer\/","title":{"rendered":"Hunter Shkolnik Discusses Teva&#8217;s $23 Billion Offer"},"content":{"rendered":"<p>Teva Pharmaceutical Industries Ltd.\u2019s proposed $23 billion drug giveaway over it\u2019s suggesting to settle the opioid lawsuits against it will likely cost the company a fraction of that figure, according to industry experts. When Teva announced the value of the donated medicine \u2013 a generic version of opioid addiction treatment Suboxone \u2013 it based the figure on the drug\u2019s list price, which does not account for significant discounts it will receive.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Teva Pharmaceutical Industries Ltd.\u2019s proposed $23 billion drug giveaway over it\u2019s suggesting to settle the opioid lawsuits against it will likely cost the company a fraction of that figure, according&#8230;<\/p>\n","protected":false},"featured_media":0,"menu_order":228,"template":"","whitepaper_category":[75,98,253,254],"whitepaper-source":[234],"class_list":["post-2655","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-legal-reader"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/whitepapers\/2655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/whitepapers\/2655\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/media?parent=2655"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/whitepaper_category?post=2655"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/en\/wp-json\/wp\/v2\/whitepaper-source?post=2655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}